|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Generation of cytokine-induced killer cells using exogenous interleukin-2,-7or12显示文摘 | ZOLL B LEFTEROVA P CSIPAI M | 1998 | Cancer Immunol Immunother1998，47，3： | 1 |
| 2 | CXCL16 is a marker of inflammation, atherosclerosis, and acutecoronary syndromes in humans 显示文摘 | LEHRKE M MILLINGTON S C LEFTEROVA M | 2007 | J Am Coll Cardiol2007，49，4： | 1 |
| 3 | CXCL16 is a Marker of Inflammation,Atherosclerosis,and Acute Coronary Syndromes in Humans显示文摘 | Lehrke M Millington SC Lefterova M | 2007 | J Am Coll Cardiol2007，49，4： | 1 |
| 4 | CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans显示文摘 | Lehrke M Millington SC Lefterova M | 2007 | J Am Coll Cardiol2007，49，4： | 1 |
| 5 | Generation of cytokine 2 induced killer cells using exogenous interleukin-2 , -7 or -12 显示文摘 | Zoll B Lefterova P Csipai M | 1998 | Cancer Immunol Immunother1998，47，4： | 1 |
| 6 | CXCL16 is a marker of inflammation,atherosclerosis,and acute coronary syndromes in humans显示文摘 | Lehrke M Millington SC Lefterova M | 2007 | J Am Coll Cardiol2007，49，4： | 1 |
| 7 | Potential of autologous immunologic effectorcells for prediction of progression of disease in patients with chronic myelogenous leukemia显示文摘 | MULLER M SCHEFFOLD C LEFTEROVA P | 1998 | Leuk Lymphoma1998，31，8： | 1 |
| 8 | New developments in adipo-genesis显示文摘 | LEFTEROVA M I LAZAR M A | 2009 | Trends Endocrinol Metab2009，20，3： | 1 |
| 9 | Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or-12显示文摘 | Zoll B Lefterova P Csipai M | 1998 | Cancer Immunol Immunother1998，47，： | 1 |
| 10 | New developments in adipo- genesis 显示文摘 | Lefterova M I Lazar M A | 2009 | Trends in Endocrinology and Metabolism2009，20，3： | 1 |
| 11 | New developments in adipogenesis显示文摘 | Lefterova M I Lazar M A | 2009 | Trends Endocrinol Metab2009，20，3： | 1 |
| 12 | Generation of cytokine induced killer cells using exogenous interleukin-2,-7or-12显示文摘 | Zoll B Lefterova P Csipai M | 1998 | Cancer Immunol Immunother1998，47，4： | 1 |
| 13 | Ge- nome-wide approaches reveal EGRl-controlled regulatory networks associated with neurodegeneration 显示文摘 | KOLDAMOVA R SCHUG J LEFTEROVA M | 2014 | Neurobiol Dis2014，63，： | 1 |
| 14 | Re-expression of GATA2 Cooperates with Peroxisome Proliferator-activated Receptor-γ Depletion to Revert the Adipocyte Phenotype显示文摘 | Schupp M Cristancho A G Lefterova M I | 2009 | Journal of BiologlcaI Chemistry2009，284，14： | 1 |
| 15 | CXCL16 is a marker of inflammation,atherosclerosis,and acute coronary syndromes in humans显示文摘 | Lehrke M Millington SC Lefterova M | | 0，，04： | 1 |
| 16 | CXCLI6 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans 显示文摘 | Lehrke M Millington SC Lefterova M et at | 2007 | J Am Coll Cardiol2007，49，4： | 1 |
| 17 | Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or -12显示文摘 | Zoll B Lefterova P Csipai M | 1998 | Cancer lmmunol lmmunother1998，47，4： | 1 |
| 18 | CXCL16 is a marker of inflammation, atheroselerosis, and acute coronary syndromes in humans显示文摘 | Lehrke M Millington S C Lefterova M | 2007 | J Am Coil Cardiol2007，49，4： | 1 |
| 19 | CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans 显示文摘 | Lehrke M Millington SC Lefterova M | 2007 | JAm Coll Cardiol2007，49，： | 1 |
| 20 | Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12显示文摘 | Zoll B Lefterova P Csipai M | 1998 | Cancer Immunol Immunother1998，47，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员